Renaissance Technologies
SLDB icon

Renaissance Technologies’s Solid Biosciences SLDB Stock Holding History

Renaissance Technologies’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$895K Buy
124,272
+71,472
+135% +$459K ﹤0.01% 2327
2025
Q4 		$298K Sell
52,800
-410,900
-89% -$2.23M ﹤0.01% 2765
2025
Q3 		$2.86M Buy
+463,700
New +$2.71M ﹤0.01% 1840
2025
Q2 		– Sell
-175,400
Closed -$649K – 3863
2025
Q1 		$649K Buy
175,400
+92,907
+113% +$398K ﹤0.01% 2628
2024
Q4 		$330K Buy
82,493
+9,281
+13% +$51K ﹤0.01% 3001
2024
Q3 		$510K Sell
73,212
-204,352
-74% -$1.66M ﹤0.01% 2784
2024
Q2 		$1.57M Buy
277,564
+208,793
+304% +$1.87M ﹤0.01% 2027
2024
Q1 		$916K Buy
68,771
+30,700
+81% +$287K ﹤0.01% 2540
2023
Q4 		$234K Buy
38,071
+9,501
+33% +$30.4K ﹤0.01% 3080
2023
Q3 		$72K Buy
28,570
+900
+3% +$3.49K ﹤0.01% 3313
2023
Q2 		$145K Sell
27,670
-11,093
-29% -$62.4K ﹤0.01% 3375
2023
Q1 		$184K Sell
38,763
-13,000
-25% -$78.1K ﹤0.01% 3304
2022
Q4 		$278K Sell
51,763
-15,722
-23% -$103K ﹤0.01% 3259
2022
Q3 		$472K Sell
67,485
-27,110
-29% -$273K ﹤0.01% 2956
2022
Q2 		$873K Buy
94,595
+10,023
+12% +$104K ﹤0.01% 2806
2022
Q1 		$1.52M Buy
84,572
+44,050
+109% +$777K ﹤0.01% 2431
2021
Q4 		$1.06M Buy
40,522
+13,732
+51% +$420K ﹤0.01% 2595
2021
Q3 		$960K Buy
26,790
+1,138
+4% +$48.3K ﹤0.01% 2574
2021
Q2 		$1.41M Buy
+25,652
New +$1.69M ﹤0.01% 2483
2021
Q1 		– Sell
-4,950
Closed -$563K – 3667
2020
Q4 		$563K Sell
4,950
-1,560
-24% -$98.7K ﹤0.01% 2767
2020
Q3 		$198K Sell
6,510
-2,190
-25% -$83.9K ﹤0.01% 3115
2020
Q2 		$382K Buy
8,700
+2,930
+51% +$122K ﹤0.01% 2956
2020
Q1 		$207K Buy
5,770
+1,901
+49% +$94.1K ﹤0.01% 3096
2019
Q4 		$258K Buy
3,869
+1,716
+80% +$189K ﹤0.01% 3105
2019
Q3 		$334K Sell
2,153
-7,867
-79% -$890K ﹤0.01% 3005
2019
Q2 		$864K Buy
10,020
+3,593
+56% +$392K ﹤0.01% 2750
2019
Q1 		$887K Buy
+6,427
New +$1.61M ﹤0.01% 2722

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies's SLDB Position: Q1 2026 in Review

Renaissance Technologies increased its Solid Biosciences (SLDB) stake by 135% in Q1 2026, buying an estimated $459K and bringing the position to 124,272 shares worth $895K. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

Renaissance Technologies first reported a position in SLDB in Q1 2019 and has held it in 27 quarters since. The position peaked at $2.86M in Q3 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Renaissance Technologies held 124,272 shares of Solid Biosciences worth $895K as of Q1 2026.
  • Renaissance Technologies bought 71,472 Solid Biosciences shares in Q1 2026, an estimated $459K.
  • Solid Biosciences made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2327 holding.
  • Renaissance Technologies first reported a position in Solid Biosciences in Q1 2019 and has held it in 27 quarters since.
  • Renaissance Technologies's Solid Biosciences position peaked at $2.86M in Q3 2025.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.